Luquain Alexandra, Belglaiaa Essaada, Guenat David, Vrecko Sindy, Riethmuller Didier, Valmary-Degano Séverine, Bedgedjian Isabelle, Chouham Said, Prétet Jean-Luc, Mougin Christiane
Centre Hospitalier Régional Universitaire de Besançon, F-25000, France.
Laboratoire de Biologie Cellulaire et Génétique Moléculaire, Faculté des Sciences, Université Ibn Zohr, Agadir, Maroc; Université Bourgogne Franche-Comté, F-25000 Besançon, France; EA 3181, LabEx LipSTIC ANR-11-LABX-0021, FED4234, CIC-1431F-25000 Besançon, France.
Prev Med. 2015 Dec;81:157-62. doi: 10.1016/j.ypmed.2015.08.018. Epub 2015 Sep 5.
To determine the prevalence of cytological abnormalities and high risk Human PapillomaVirus (hrHPV) in cervical smears from French women aged over 65 years who attended the referent Gynecology Clinic of the Besançon University Hospital.
Between 2002 and 2012, 796 French women aged 66-99 years were cotested for cytology and hrHPV by Hybrid Capture 2 (hc2). hc2-positive cases were subjected to real time PCR for specific HPV 16/18/45 genotyping. Women with normal Pap smears and positive for hrHPV were followed-up every 12 months.
Cytological abnormalities were detected in more than 30% of women and cervical cancers (CC) in 2.9% of women. Benign lesions were more frequent in women aged 66-75 years while (pre)-malignant lesions were preferentially found in women over 76. The prevalence of hrHPV was 22.7%. HPV 16 was the most frequent (23.8%), followed by HPV 45 (7.7%) and HPV 18 (3.9%). The rate of hrHPV increased with the lesion severity and HPV 16 was identified in 50% of CC. Among the followed-up women, those who developed CIN3 were HPV16 positive at study entry.
The study provides important estimates of the prevalence of cervical abnormalities and hrHPV positivity in a French hospital based-population over 65. Findings suggest to consider this high risk population in regards to cervical cancer.
确定在贝桑松大学医院妇科转诊诊所就诊的65岁以上法国女性宫颈涂片细胞学异常和高危型人乳头瘤病毒(hrHPV)的患病率。
2002年至2012年期间,对796名年龄在66 - 99岁的法国女性进行了细胞学和hrHPV联合检测(采用杂交捕获2代检测法)。对杂交捕获2代检测法呈阳性的病例进行实时聚合酶链反应,以进行特定的HPV 16/18/45基因分型。巴氏涂片正常但hrHPV呈阳性的女性每12个月进行一次随访。
超过30%的女性检测到细胞学异常,2.9%的女性检测到宫颈癌(CC)。良性病变在66 - 75岁的女性中更为常见,而(癌)前病变则主要在76岁以上的女性中发现。hrHPV的患病率为22.7%。HPV 16最为常见(23.8%),其次是HPV 45(7.7%)和HPV 18(3.9%)。hrHPV的感染率随病变严重程度增加,在50%的宫颈癌病例中检测到HPV 16。在随访的女性中,那些发展为CIN3的女性在研究开始时HPV16呈阳性。
该研究提供了在一家法国医院的65岁以上人群中宫颈异常和hrHPV阳性患病率的重要估计值。研究结果表明在宫颈癌方面应考虑这一高危人群。